See more : Nissan Shatai Co., Ltd. (7222.T) Income Statement Analysis – Financial Results
Complete financial analysis of Mind Cure Health Inc. (MCURF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mind Cure Health Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Pharmaxis Ltd (PXS.AX) Income Statement Analysis – Financial Results
- Garmin Ltd. (GRMN) Income Statement Analysis – Financial Results
- Namchow Holdings Co., Ltd. (1702.TW) Income Statement Analysis – Financial Results
- Corebridge Financial, Inc. (CRBG) Income Statement Analysis – Financial Results
- Enterprise Financial Services Corp (EFSCP) Income Statement Analysis – Financial Results
Mind Cure Health Inc. (MCURF)
About Mind Cure Health Inc.
Mind Cure Health Inc., a life sciences company, develops and commercializes mental health and wellness products in North America. It focuses on the development of digital therapeutics technology and researching psychedelic compounds to rapidly scale science-backed and evidence-based mental health therapy. The company develops iSTRYM, a digital therapeutics tool and first-of-its-kind software application that optimizes the healing journey for patients and clinicians before, during, and after therapy sessions; PsyCollage, a bioinformatics platform that helps to drive research by identifying priority research programs; synthetic ibogaine to supply researchers and clinicians; and psychedelic compounds, including ibogaine for traumatic brain injuries and related conditions. Mind Cure Health Inc. was incorporated in 2020 and is headquartered in Vancouver, Canada.
| Metric | 2022 | 2021 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% |
| Research & Development | 48.25K | 50.36K |
| General & Administrative | 9.74M | 10.21M |
| Selling & Marketing | 262.69K | 204.55K |
| SG&A | 10.00M | 10.41M |
| Other Expenses | 0.00 | 0.00 |
| Operating Expenses | 10.06M | 10.46M |
| Cost & Expenses | 10.06M | 10.46M |
| Interest Income | 94.41K | 33.25K |
| Interest Expense | 0.00 | 0.00 |
| Depreciation & Amortization | 9.75K | 236.56K |
| EBITDA | -5.88M | -10.73M |
| EBITDA Ratio | 0.00% | 0.00% |
| Operating Income | -5.89M | -10.73M |
| Operating Income Ratio | 0.00% | 0.00% |
| Total Other Income/Expenses | -8.25M | 789.04K |
| Income Before Tax | -14.14M | -10.17M |
| Income Before Tax Ratio | 0.00% | 0.00% |
| Income Tax Expense | 4.08M | 0.00 |
| Net Income | -14.14M | -10.17M |
| Net Income Ratio | 0.00% | 0.00% |
| EPS | -0.15 | -0.18 |
| EPS Diluted | -0.15 | -0.18 |
| Weighted Avg Shares Out | 93.85M | 57.31M |
| Weighted Avg Shares Out (Dil) | 93.85M | 57.31M |
MINDCURE to Participate in Upcoming Conferences in December 2021
MINDCURE to Webcast Live at the KCSA Psychedelics Virtual Investor Conference on October 13, 2021
OTC Markets Group Welcomes Mind Cure Health Inc. to OTCQX
MINDCURE Launches "Desire Project" To Treat Female Hypoactive Sexual Desire Disorder With MDMA-Assisted Psychotherapy
MINDCURE Signs Exclusive Digital Clinical Data Licensing Agreement with ATMA Journey Centers
MINDCURE Announces Inclusion in AdvisorShares Psychedelics ETF
MINDCURE to Participate in Maxim Group LLC's Advances in Mental Health Virtual Conference
MINDCURE Joins Digital Therapeutics Alliance to Drive Innovation in the Mental Health Industry
MINDCURE Announces Platinum Sponsorship of the 2021 SANA Symposium
MINDCURE to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Source: https://incomestatements.info
Category: Stock Reports